DOP001: European Crohn’s and Colitis Organisation topical review on environmental factors in IBDECCO'17 Barcelona 2017
1
DOP002: Trends in small bowel resections for Crohn’s disease with and without short bowel syndrome in the era of biologicsECCO'17 Barcelona 2017
1
DOP003: Proximal disease extension in patients with limited Ulcerative Colitis: a Danish population-based inception cohortECCO'17 Barcelona 2017
1
DOP004: Ethnicity and country of birth are associated with phenotypic differences in patients with Inflammatory Bowel DiseaseECCO'17 Barcelona 2017
1
DOP005: Proximal disease extension in limited Ulcerative Colitis: A systematic review and meta-analysisECCO'17 Barcelona 2017
1
DOP006: Research gaps in diet and nutrition in Inflammatory Bowel Disease. A topical review by ECCOECCO'17 Barcelona 2017
1
DOP008: Dietary manipulation of the healthy human and Colitic murine gut microbiome by CD-TREAT diet and exclusive enteral nutrition; a proof of concept studyECCO'17 Barcelona 2017
1
DOP009: Choice of corticosteroids or exclusive enteral nutrition as the first induction of remission therapy does not affect disease behavior within two years of diagnosisECCO'17 Barcelona 2017
1
DOP010: ECCO Topical Review on Transitional Care in Inflammatory Bowel DiseaseECCO'17 Barcelona 2017
1
DOP011: Risk of opportunistic infection in healthcare personnel with Inflammatory Bowel Disease: A case-control study of the GETAIDECCO'17 Barcelona 2017
1
DOP012: Impact on clinical practice of Epstein-Barr virus infection in patients with Inflammatory Bowel DiseaseECCO'17 Barcelona 2017
1
DOP013: Definition of therapeutic response criteria using MRI in Crohn’s Disease patients treated with anti-TNF therapy: A multicenter prospective study (the IRMA study)ECCO'17 Barcelona 2017
1
DOP014: Transmural healing is better than mucosal healing in Crohn's DiseaseECCO'17 Barcelona 2017
1
DOP015: International differences in gastroenterologists’ perspective on stopping therapy for patients with Crohn’s DiseaseECCO'17 Barcelona 2017
1
DOP016: Long-term safety of in utero exposure to anti-tumor necrosis factor for the treatment of Inflammatory Bowel Diseases: Results from the multicenter European TEDDY studyECCO'17 Barcelona 2017
1
DOP017: Patterns of anti-TNF use and associated treatment outcomes in Inflammatory Bowel Disease patients: Results from an analysis of Dutch health insurance claims dataECCO'17 Barcelona 2017
1